1. Governance Presets
2. Framework Controls
Eligibility Classification
Female Category Restricted to Biological Females (XX/Non-Y-Gene); Open Category Available for Inclusive Participation
Biological Integrity & Fairness Rating
High Biological Integrity
Fairness Score: 92/100
Inclusion Scope Rating
Moderate (Structured via Open Category)
Inclusion Score: 68/100
Medical Privacy Compliance
Compliant with WADA/WTA Medical Privacy Protocols
WADA/WTA Compliant
Governance Trade-Off Index
Athlete Category Eligibility Pathway
3. Policy Impact Assessment & Comparative Summary
WTA 2026 Framework Assessment
Under the current selection (WTA 2026 Preset), the female category enforces non-Y-gene chromosomal screening and an endogenous testosterone cap of 2.5 nmol/L monitored over 24 months. This structure protects biological integrity in elite women's competition while providing an inclusive Open Category for all athletes. Medical data is protected via an independent encrypted medical board complying with WADA standards.
| Governing Body | Category Model | Gene / Y-Chrom Screening | T-Limit (nmol/L) | Monitoring | Privacy Level |
|---|